September 2023 - NetworkNewsWire

ThursdaySep 21, 2023 11:15 am

Charting the Future of Biopharma and Medical Devices: DGE’s 2nd Chief Commercial Officer Summit Convenes Industry Leaders in Philadelphia

DGE invites biotech, pharmaceutical and medical device leaders to attend the 2nd Chief Commercial Officer Summit to be held at The Bellevue Hotel, Philadelphia, PA, October 4-5, 2023. The much-awaited summit aims to chart the remarkable future of the biotech, pharmaceutical and medical device industries. The landmark event will feature a gathering of thought leaders and visionaries dedicated to driving commercial growth in the industry. The role of Chief Commercial Officers (“CCOs”) has gained more significance with the progression of the life sciences landscape. The 2nd Chief Commercial Officer Summit provides a unique platform to explore key strategies for advancing…

ThursdaySep 21, 2023 10:30 am

New Orleans Investment Conference: Shaping the Future of Investment Innovation

Investors, policymakers, enthusiasts, technologists, decision-makers, and business owners are invited to attend the New Orleans Investment Conference to be held in New Orleans, Louisiana, November 1-4, 2023. The 2023 edition of this iconic event is committed to paving the way to real investment insights and financial wisdom in a fast-changing economic landscape. Having a rich history of successful investment symposiums, the New Orleans Investment Conference has consistently brought together some of the brightest minds in finance, politics, and economics. The conference will feature a lineup of world-renowned speakers who will share valuable investment strategies to unlock the secrets of financial…

ThursdaySep 21, 2023 9:45 am

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) Is ‘One to Watch’

In September 2023, Sekur Private Data announced that it had signed a distribution agreement with VYRE Network, a leading news-based streaming channel and website, for the Sekur suite of solutions The company has no debt and no convertible equity Sekur Private Data in June 2023 announced that it is on track to launch Sekur Enterprise Solutions, its new product for SMBs, large enterprises and government organizations The company plans to launch SekurIdentity, its new identity theft protection solution, in 2024 Sekur Private Data plans international business expansions in Latin America, Australia and Europe in 2024 Sekur Private Data (CSE: SKUR)…

ThursdaySep 21, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) to Demonstrate DehydraTECH-CBD Benefits in Upcoming Investigational New Drug Application Submission

Lexaria’s IND application builds on five previous human clinical studies showing zero serious adverse effects and evidencing a reduction in resting blood pressure in test subjects DehydraTECH(TM)-CBD has the potential to have pronounced clinical benefits relative to the available anti-hypertensive therapeutics on the market today Work mostly under Lexaria’s control was completed earlier this year, including the batch manufacturing of DehydraTECH-CBD and placebo materials necessary for the IND application Lexaria is waiting to submit until the necessary documentation outside of their control is ready for the IND application Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains…

WednesdaySep 20, 2023 1:30 pm

Innovating Medical Devices Design: DGE’s 4th Human Factors Engineering & Usability Studies Congress Convenes in Philadelphia

DGE invites medical device design, safety, and compliance professionals to attend the 4th Human Factors Engineering & Usability Studies Congress to be held at The Bellevue Hotel, Philadelphia, PA, October 4-5, 2023. The distinguished event serves as a decisive knowledge-sharing platform focused on the complicated procedural, technical, and collaborative challenges that usability teams face. The 4th Human Factors Engineering & Usability Studies Congress focuses on understanding and meeting FDA expectations, working with diverse user groups, recognizing the role of user fear and embarrassment, and determining just how much realistic detail is necessary for simulated use environments. Improved User Experience and…

WednesdaySep 20, 2023 12:45 pm

EV Charging Infrastructure Summit: A Step Towards Sustainable Future

Investors, industry leaders, decision-makers, and business owners, are invited to attend the GSMI “EV Charging Infrastructure Summit”, September 27-28, 2023. This virtual event will explore sustainable energy solutions while driving advancement and positive change within the industry. Featuring interactive panel discussions and insightful keynote presentations, the EV Charging Infrastructure Summit offers an important platform for innovation and collaboration. As the electric vehicle trend is gaining momentum, businesses are looking for an accessible and robust EV charging infrastructure. Serving as a beacon of technological innovation, the EV Charging Infrastructure Summit promises to pave the path for a greener and cleaner future.…

WednesdaySep 20, 2023 11:15 am

Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources

California-based cancer fighter Renovaro BioSciences is turning the power of its immune system-promoting technology to the fight against pancreatic cancer and other illnesses that tend to leave patients with a short life expectancy once they are diagnosed Renovaro recently announced a binding, exclusive letter of intent (“LOI”) to add GEDI Cube’s artificial intelligence (“AI”) data mining technology to its fight against such cancers GEDI Cube is strengthening its platform’s potential by joining with the NVIDIA Inception program, which nurtures start-ups by providing access to cutting-edge technology, technical resources, and venture capitalists The companies hope to detect pancreatic tumors at early…

WednesdaySep 20, 2023 10:30 am

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Exploration at Deer Horn Provides Key Data for September Drill Program

CEO notes that prospecting, mapping and sampling have provided an extensive base of information to support drilling and IP survey Last month’s property-wide mapping and sampling program confirmed a structural connection between two key sections of the property This month’s drilling program will test the extent of the mineralization and study how the systems at Deer Horn and Pond are related First Tellurium (CSE: FTEL) (OTCQB: FSTTF) has wrapped up a property-wide mapping and sampling program at its Deer Horn property in west-central British Columbia and is preparing to launch a drill program later this month (https://nnw.fm/7CPql). Based on data…

WednesdaySep 20, 2023 9:45 am

Electronic Servitor Publication Network Inc. (XESP) Provides Unique Digital Engagement Offering in Revenue-Driven Customer Engagement Solutions Market

The global customer engagement solutions market is growing exponentially, driven by reduced churn rates and a preference for e-commerce platforms Larger companies in the industry, like Service Now, Salesforce, and OpenAI, have seen significant revenue and market caps based on their marketing offerings Electronic Servitor Publication Network’s Digital Engagement Engine(TM) offers a unique multi-channel digital engagement experience that allows for targeting the narrowest of niches Valued at $19.3 billion in 2022, the global customer engagement solutions market is expected to grow at a CAGR of 10.8% through 2027, with a value of $32.2 billion. Factors contributing to this growth are…

WednesdaySep 20, 2023 9:00 am

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

NetworkNewsWire Editorial Coverage: More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation of new treatments, particularly for rare diseases, is a key priority for the U.S. Food & Drug Administration. As part of that process, the agency can grant Orphan Drug Designation (“ODD”) to a drug or biological product being developed to prevent, diagnose or treat a rare disease or condition. This designation is intended to spark innovation among biotech companies that are developing treatments for these patient populations, which by definition affect…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Month: September 2023